- Hardcover: 384 pages
- Publisher: Springer; 3rd ed. edition (May 6, 2010)
- Language: English
- ISBN-10: 3642108199
- ISBN-13: 978-3642108198
This book is the first complete guide to valuation in life sciences for
industry professionals, investors, and academics. Boris Bogdan and Ralph
Villiger introduce the characteristics of drug and medical device
development, explain how to translate these into the valuation, and
provide valuable industry data. After guiding the reader through the
theory of valuation, including DCF, decision trees, and real options,
the authors demonstrate how to value projects, patents, licences, firms,
and stocks on real-life examples, even treating complex licence and
company structures. Special emphasis is put on the practicability of the
proposed methods by including many hands-on examples, without
compromising on realistic results. The 3rd edition of the successful
work includes new studies about success rates and about drug development
in the biotech industry and their influence on valuation.
No comments:
Post a Comment